Effects of fatty and lean fish intake on blood pressure in subjects with coronary heart disease using multiple medications

Dept of Public Health, School of Public Health and Clinical Nutrition, University of Kuopio, Kuopio, Finland.
European Journal of Nutrition (Impact Factor: 3.47). 09/2008; 47(6):319-28. DOI: 10.1007/s00394-008-0728-5
Source: PubMed


Intake of fish and long-chain n-3 fatty acids has been of wide interest due to their beneficial effects on cardiovascular risk factors and lower coronary heart disease (CHD) risk.
The aim of this pilot study was to examine the effects of fatty fish and lean (white) fish on fatty acid composition of serum lipids and cardiovascular risk factors in subjects with CHD using multiple drugs for this condition.
The study was an 8-week controlled, parallel intervention. Inclusion criteria were myocardial infarction or unstable ischemic attack, age under 70 years, use of betablockers and presence of sinus rhythm. The subjects were randomized to one of the following groups: 4 meals/week fatty fish (n = 11), 4 meals/week lean fish (n = 12) and control diet including lean meat (n = 10).
The mean (+/-SD) of reported fish meals per week was 4.3 +/- 0.4, 4.7 +/- 1.1 and 0.6 +/- 0.4 in the groups, respectively. The proportions of eicosapentaenoic and docosahexaenoic acids in serum lipids increased in the fatty fish group only (P < 0.05). Systolic and diastolic blood pressure levels decreased in the lean fish group (0 vs. 8 week: 3.5 +/- 3.2 and 4.6 +/- 3.6%, respectively, P < 0.05). Serum total triglyceride concentration did not significantly change. HDL cholesterol concentration change differed among groups but without significant post hoc differences. Apolipoprotein A-1 concentration decreased in the control group (0 vs. 8 week, P < 0.05). Coagulation factors, 25-hydroxy vitamin D, and heart rate variability (24 h Holter) did not change among the groups.
Our results suggest that intake of lean fish at least four times per week could reduce blood pressure levels in CHD patients.

7 Reads
  • Source
    • "fatty acid content of the fish is important, but also other nutrients in fish may influence on CVD. In this sense, Erkkilä et al. found that the intake of lean fish at least four times per week could reduce blood pressure levels in coronary heart disease patients [113]. Likewise, there are also some evidences that suggest benefits on body weight [114] [115]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The prevalence of metabolic syndrome (MetS) manifestations is rapidly increasing worldwide, and is becoming an important health problem. Actually, MetS includes a combination of clinical complications such as obesity (central adiposity), insulin resistance, glucose intolerance, dyslipidemia, non-alcoholic fatty liver disease and hypertension. All these alterations predispose individuals to type 2 diabetes and cardiovascular disease inducing earlier mortality rates among people. In general terms, it is difficult for patients to follow a standard long-term diet/exercise regime that would improve or alleviate MetS symptoms. Thus, the investigation of food components that may deal with the MetS features is an important field for ameliorate and facilitate MetS dietary-based therapies. Currently antioxidants are of great interest due to the described association between obesity, cardiovascular alterations and oxidative stress. On the other hand, high MUFA and PUFA diets are being also considered due to their potential benefits on hypertension, insulin resistance and triglyceride levels. Mineral composition of the diet is also relevant since high potassium intake may improve hypertension and high calcium consumption may promote lipid oxidation. Thus, although nutritional supplements are at the peak of dietetic therapies, the consumption of some specific foods (legumes, fatty fish, vegetables and fruits, etc) with bioactive components within an energy-restricted diet is a promising approach to manage MetS manifestations. Therefore, the present review focuses on some of the most important food components currently investigated to improve and make easier the nutritional MetS treatment.
    Nutrition, metabolism, and cardiovascular diseases: NMCD 07/2011; 21 Suppl 2(Suppl 2):B1-15. DOI:10.1016/j.numecd.2011.05.001 · 3.32 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Die demografische Entwicklung zeigt eine Zunahme der älteren Bevölkerung mit zahlreichen Vorerkrankungen. Insbesondere die Prävalenz der koronaren Herzerkrankung steigt mit zunehmendem Lebensalter rapide an und erhöht das Risiko für eine perioperative Myokardischämie. In den letzten Jahren sind multimodale Therapiekonzepte entwickelt worden, um z. B. schwerwiegende kardiale Ereignisse zu vermeiden und damit das perioperative Risiko zu reduzieren. Zu diesen Therapiekonzepten zählt der Einsatz kardioprotektiv wirkender Medikamente, wie z. B. β-Rezeptoren-Blocker und Statine. Die aktuellen Leitlinien beinhalten im Sinne einer Klasse-I-Empfehlung die perioperative Fortführung, sowohl einer chronischen Therapie mit β-Rezeptoren-Blockern als auch mit Statinen. Das Verfahren der Konditionierung ist experimentell gut erforscht und hat auch klinisch tendenzielle Effekte. Neben der klassischen ischämischen und anästhetikainduzierten Präkonditionierung ist das nichtinvasive Verfahren der Fernpräkonditionierung für viele Patienten besonders interessant. Große randomisierte, multizentrische Studien sind hierbei für eine abschließende Aussage notwendig. Obwohl die Studienlage für die Durchführung einer Regionalanästhesie bezüglich Kardioprotektion sehr heterogen ist, hat sie einen besonderen Stellenwert im Rahmen der perioperativen Schmerztherapie und sollte daher als ein Teil der multimodalen Therapiekonzepte mit genutzt werden.
    Der Anaesthesist 11/2011; 60(11). DOI:10.1007/s00101-011-1943-7 · 0.76 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Une mort cellulaire par apoptose impliquant un processus inflammatoire est observée dans le système limbique, suite à un infarctus du myocarde. Les oméga-3 et ses métabolites, en plus de leurs propriétés bénéfiques pour le système cardiovasculaire, réduisent l’inflammation, contrairement aux oméga-6 qui sont plus pro-inflammatoires. Comme le métabolisme de ces deux acides gras essentiels impliquent les mêmes enzymes, le ratio alimentaire oméga-3/6 aurait donc des impacts importants sur l'état inflammatoire et ainsi indirectement sur l'apoptose. Conséquemment, cette étude a pour but d'évaluer l'effet de différents ratios oméga-3/6 sur la taille de l’infarctus, l’inflammation et l’apoptose dans le système limbique suite à un infarctus du myocarde. Des rats Sprague-Dawley ont été aléatoirement distribués dans trois groupes contenant des ratios 1:1, 1:5 et 5:1 oméga-3/6. Ils ont été nourris pendant 2 semaines, suivie d’une occlusion de l’artère coronaire gauche descendante pendant 40 minutes et d’une période de reperfusion (15 min et 24 h). De hauts ratios d’oméga-3 (5:1 et 1:1) diminuent significativement la taille de l’infarctus de 32 % et augmentent l’activité d’Akt, impliquée dans la voie cardioprotectrice RISK, comparativement au ratio 1:5. Ils diminuent aussi la concentration plasmatique de TNF-D. Dans le système limbique, l’activité de la caspase-3 est augmentée dans la région CA1, après 15 min, et dans les régions du CA1 et du gyrus dentelé (Gd), après 24 h, avec la diète 1:5 en comparaison aux diètes 1:1 et 5:1. L’activité enzymatique de la caspase-8 est augmentée dans le Gd, alors que dans le CA1, il y a une activité plus importante de la caspase-9 aux temps de reperfusion étudiés. Conclusion: Les diètes élevées en oméga-3/oméga-6 réduisent la taille de l'infarctus, l’inflammation et diminuent l’apoptose dans le système limbique après un infarctus du myocarde. Apoptosis occurs in the limbic system by a mechanism involving inflammation after a myocardial infarction. Omega-3 are essential fatty acids known for their benefits in cardiovascular health and to reduce inflammation, whereas, omega-6 and their metabolites are more inflammatory. Since these two essential fatty acids are metabolized by the same group of enzymes, the resulting competition would affect the inflammation and thus indirectly the apoptosis. Therefore, the aim of this study is to evaluate the effect of different omega-3/6 ratios on the infarct size, inflammation and apoptosis in the limbic system after myocardial infarction. Male Sprague-Dawley rats were divided randomly between three diet groups containing 1:5, 1:1 and 5:1 omega-3/6 ratios. Rats were fed for two weeks followed by a left anterior descending coronary occlusion for 40 min and by reperfusion time (15 min or 24 h). Infarct size was significantly reduced by 32% and Akt activity, implicated in RISK cardioprotection pathway, enhanced by the 5:1 and 1:1 in comparison to the 1:5 diet ratios. They also reduced TNF-D plasma concentration. In the limbic system, caspase-3 enzymatic activity was doubled in CA1 after 15 min and in CA1 and dentate gyrus (Dg), after 24 h, in the 1:5 compared to 1:1 and 5:1 groups. Caspase-8 enzymatic activity was increased in Dg and capase-9 was enhanced in the CA1 at both reperfusion time in the 1:5 against the 1:1 and 5:1 groups. Conclusion: High omega-3 dietary ratio helps to reduce infarct size, inflammation and to prevent apoptosis in the limbic system.
Show more